MTM was created with YOU in mind. This is a free service that you will automatically be enrolled in if you qualify. Your MTM can be completed on the telephone from the comfort of your own home and you can take your time asking questions about your medications and medical conditions. Once enrolled you can opt-out of the MTM program at any time.
For 2024, in order to qualify for the MTM program, you must:
Once you qualify you will receive a welcome packet that includes instructions on how to complete your MTM appointment. You will also receive calls throughout the year to remind you to schedule your MTM appointment and/or complete it with the pharmacist at that time.
First, you’ll have a call with a pharmacist or other health care professional to complete a comprehensive medication review (CMR). This call usually takes around 20 minutes. During this call you will:
After your call you will receive a written CMR summary of your MTM appointment in the mail. This summary will include the medication list you reviewed during the appointment and a recommended to-do list with counseling points and next steps for you to take. Your CMR summary will include information like:
Having this information can help you see your overall health picture. It can also help you and your doctor make any changes.
Keeping your care team informed on your prescription drugs is one way to achieve whole care. Your MTM summary is a tool to use on a regular basis. You can bring it to:
You can also use it when you and your doctor review drugs on your Medicare D-SNP Diamond and Ruby Drug List.
If you have questions about your MTM Program or your prescription benefits, please call Member Services at 1-844-339-7684 (TTY 711).
Health benefits or health benefit administration may be provided by or through Highmark Wholecare, an independent licensee of the Blue Cross Blue Shield Association (“Highmark Wholecare”). Highmark Wholecare offers HMO plans with a Medicare Contract. Enrollment in these plans depends on contract renewal.
Medicare Ombudsman Website
Best Available Evidence
Y0037_1359_M_2025
Last Updated: Oct 1, 2024